Trial Outcomes & Findings for Role of the Protein Matrix in the Anabolic Response to a Ground Beef Patty as Opposed to the Impossible (Vegi-) Burger (NCT NCT05197140)
NCT ID: NCT05197140
Last Updated: 2024-08-05
Results Overview
Free leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan (combined) (µmol·L\^(-1)·min). Following time points (in minutes) post-ingestion will be used to calculate the incremental area under the curve: 60, 90, 120, 180, 210, 240, 270, 300, 330, 360.
COMPLETED
NA
33 participants
6 hours after consumption of intervention
2024-08-05
Participant Flow
Participant milestones
| Measure |
4 Ounce Beef Patty
Subjects consume one beef patty of 4 ounces of cooked meat.
food: cooked 85% lean ground beef: see arm description
|
4 Ounce Vegetarian Burger
Subjects consume one patty of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
2x 4 Ounce Vegetarian Burger
Subjects consume two patties of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
|---|---|---|---|
|
Overall Study
STARTED
|
11
|
11
|
11
|
|
Overall Study
COMPLETED
|
8
|
8
|
8
|
|
Overall Study
NOT COMPLETED
|
3
|
3
|
3
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Role of the Protein Matrix in the Anabolic Response to a Ground Beef Patty as Opposed to the Impossible (Vegi-) Burger
Baseline characteristics by cohort
| Measure |
4 Ounce Beef Patty
n=8 Participants
Subjects consume one beef patty of 4 ounces of cooked meat.
food: cooked 85% lean ground beef: see arm description
|
4 Ounce Vegetarian Burger
n=8 Participants
Subjects consume one patty of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
2x 4 Ounce Vegetarian Burger
n=8 Participants
Subjects consume two patties of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
Total
n=24 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
8 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
24 Participants
n=4 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Age, Continuous
|
30.0 years
STANDARD_DEVIATION 7.4 • n=5 Participants
|
36.5 years
STANDARD_DEVIATION 4.2 • n=7 Participants
|
28.9 years
STANDARD_DEVIATION 5.8 • n=5 Participants
|
32.5 years
STANDARD_DEVIATION 6.5 • n=4 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
14 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
7 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
22 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
8 participants
n=5 Participants
|
8 participants
n=7 Participants
|
8 participants
n=5 Participants
|
24 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: 6 hours after consumption of interventionFree leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan (combined) (µmol·L\^(-1)·min). Following time points (in minutes) post-ingestion will be used to calculate the incremental area under the curve: 60, 90, 120, 180, 210, 240, 270, 300, 330, 360.
Outcome measures
| Measure |
4 Ounce Beef Patty
n=8 Participants
Subjects consume one beef patty of 4 ounces of cooked meat.
food: cooked 85% lean ground beef: see arm description
|
4 Ounce Vegetarian Burger
n=8 Participants
Subjects consume one patty of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
2x 4 Ounce Vegetarian Burger
n=8 Participants
Subjects consume two patties of 4 ounces of cooked vegetarian product.
food: Impossible Burger (R): see arm description
|
|---|---|---|---|
|
Postprandial Plasma Essential Amino Acid Concentration Incremental Area-under-the-curve [ Time Frame: 360 Minutes]
|
117896 micromoles per liter per minute
Standard Deviation 45787
|
75098 micromoles per liter per minute
Standard Deviation 45231
|
94058 micromoles per liter per minute
Standard Deviation 27252
|
Adverse Events
4 Ounce Beef Patty
4 Ounce Vegetarian Burger
2x 4 Ounce Vegetarian Burger
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Robert Wolfe
University of Arkansas for Medical Sciences
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place